Features predicting colchicine efficacy in treatment of children with undefined systemic autoinflammatory disease: A retrospective cohort study.

Mariana Correia MarquesBuğra Han EgeliHolly WobmaClaudio RibeiroEdwin AndersonJonathan S HausmannFatma Dedeoğlu

Published in: European journal of rheumatology (2022)

Colchicine leads to clinical benefits in most children with uSAID. We, thus, recommend an early trial of colchicine in newly diagnosed patients with uSAID.

Keyphrases

newly diagnosed
young adults
clinical trial
phase iii
phase ii
combination therapy
open label
smoking cessation